{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:44:42Z","timestamp":1792079082797,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.chest.2023.01.009","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T10:29:41Z","timestamp":1673692181000},"page":"206-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Portopulmonary Hypertension"],"prefix":"10.1016","volume":"164","author":[{"given":"Hilary M.","family":"DuBrock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.chest.2023.01.009_bib1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension: a report from the US-based REVEAL Registry","volume":"141","author":"Krowka","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2023.01.009_bib2","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.chest.2023.01.009_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/lt.500060209","article-title":"A\u00a0spectrum of pulmonary vascular pathology in portopulmonary hypertension","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.chest.2023.01.009_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/20458940211020913","article-title":"Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry","volume":"11","author":"DuBrock","year":"2021","journal-title":"Pulm Circ"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/jhep.2003.50060","article-title":"Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study","volume":"37","author":"Colle","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.chest.2023.01.009_bib8","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.21431","article-title":"Portopulmonary hypertension: results from a 10-year screening algorithm","volume":"44","author":"Krowka","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.chest.2023.01.009_bib9","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International Liver Transplant Society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jhep.2013.03.026","article-title":"Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward","volume":"59","author":"Krowka","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.chest.2023.01.009_bib11","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transplant"},{"issue":"38","key":"10.1016\/j.chest.2023.01.009_bib12","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.chest.2023.01.009_bib13","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.chest.2023.01.009_bib14","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3748\/wjg.v20.i10.2555","article-title":"Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis","volume":"20","author":"Bolognesi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"8744","key":"10.1016\/j.chest.2023.01.009_bib15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0140-6736(91)91384-7","article-title":"Hyperdynamic circulation in cirrhosis: a role for nitric oxide?","volume":"337","author":"Vallance","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib16","doi-asserted-by":"crossref","first-page":"2200107","DOI":"10.1183\/13993003.00107-2022","article-title":"Outcomes of cirrhotic patients with pre-capillary pulmonary hypertension and pulmonary vascular resistance between 2 and 3 Wood units","volume":"60","author":"Certain","year":"2022","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.chest.2023.01.009_bib18","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/hep.20704","article-title":"AASLD practice guidelines: evaluation of the patient for liver transplantation","volume":"41","author":"Murray","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.chest.2023.01.009_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/lt.23649","article-title":"Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values","volume":"19","author":"Raevens","year":"2013","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.chest.2023.01.009_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13585","article-title":"Noninvasive estimation of pulmonary vascular resistance improves portopulmonary hypertension screening in liver transplant candidates","volume":"33","author":"DesJardin","year":"2019","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.chest.2023.01.009_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.chest.2023.01.009_bib22","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1053\/j.gastro.2011.06.053","article-title":"Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment","volume":"141","author":"Talwalkar","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.31314","article-title":"Estrogen signaling and portopulmonary hypertension: the Pulmonary Vascular Complications of Liver Disease Study (PVCLD2)","volume":"73","author":"Al-Naamani","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.chest.2023.01.009_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.gastro.2010.03.044","article-title":"Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease","volume":"139","author":"Roberts","year":"2010","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.chest.2023.01.009_bib25","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1164\/rccm.201912-2514LE","article-title":"BMP9\/10 in pulmonary vascular complications of liver disease","volume":"201","author":"Rochon","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.chest.2023.01.009_bib26","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/gut.52.9.1355","article-title":"Portopulmonary hypertension in decompensated cirrhosis with refractory ascites","volume":"52","author":"Benjaminov","year":"2003","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.chest.2023.01.009_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1086\/688489","article-title":"Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension","volume":"6","author":"DuBrock","year":"2016","journal-title":"Pulm Circ"},{"issue":"7","key":"10.1016\/j.chest.2023.01.009_bib28","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/rccm.201807-1236OC","article-title":"Bone morphogenetic protein 9 is a mechanistic biomarker of portopulmonary hypertension","volume":"199","author":"Nikolic","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2023.01.009_bib29","doi-asserted-by":"crossref","first-page":"1801889","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Galie","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2023.01.009_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/528783","article-title":"Effect of PAH specific therapy on pulmonary hemodynamics and six-minute walk distance in portopulmonary hypertension: a systematic review and meta-analysis","volume":"2014","author":"Faisal","year":"2014","journal-title":"Pulm Med"},{"issue":"5","key":"10.1016\/j.chest.2023.01.009_bib31","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/hep.31164","article-title":"Vasomodulators and liver transplantation for portopulmonary hypertension: evidence from a systematic review and meta-analysis","volume":"72","author":"Deroo","year":"2020","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.chest.2023.01.009_bib32","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/lt.20153","article-title":"Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation","volume":"10","author":"Makisalo","year":"2004","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018769305","article-title":"Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1\/-2 studies","volume":"8","author":"Cartin-Ceba","year":"2018","journal-title":"Pulm Circ"},{"issue":"1","key":"10.1016\/j.chest.2023.01.009_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","article-title":"Portopulmonary hypertension in the current era of pulmonary hypertension management","volume":"73","author":"Savale","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.chest.2023.01.009_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102071","article-title":"Effects of sildenafil on right ventricle remodelling in portopulmonary hypertension","volume":"70","author":"Rossi","year":"2021","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.chest.2023.01.009_bib36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1183\/09031936.05.00080804","article-title":"Bosentan therapy for portopulmonary hypertension","volume":"25","author":"Hoeper","year":"2005","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2023.01.009_bib37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1183\/09031936.00117511","article-title":"Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension","volume":"41","author":"Savale","year":"2013","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2023.01.009_bib38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.healun.2019.12.008","article-title":"Ambrisentan in portopulmonary hypertension: a multicenter, open-label trial","volume":"39","author":"Preston","year":"2020","journal-title":"J Heart Lung, Transplant"},{"issue":"7","key":"10.1016\/j.chest.2023.01.009_bib39","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","article-title":"Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial","volume":"7","author":"Sitbon","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.chest.2023.01.009_bib40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/lt.25747","article-title":"Macitentan improves risk categorization for liver transplant mortality in patients with portopulmonary hypertension: a PORTICO study post hoc analysis","volume":"26","author":"Krowka","year":"2020","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.chest.2023.01.009_bib41","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007890-199702270-00020","article-title":"Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension","volume":"63","author":"Kuo","year":"1997","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.chest.2023.01.009_bib42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/lt.500050517","article-title":"Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension","volume":"5","author":"Findlay","year":"1999","journal-title":"Liver Transpl Surg"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: the REVEAL Risk Score Calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.chest.2023.01.009_bib44","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Galie","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2023.01.009_bib45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.30197","article-title":"Treatment barriers in portopulmonary hypertension","volume":"69","author":"AbuHalimeh","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.chest.2023.01.009_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.chest.2023.01.009_bib47","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/lt.24198","article-title":"Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival","volume":"21","author":"Fussner","year":"2015","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.chest.2023.01.009_bib48","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/lt.26422","article-title":"Mending the model for end-stage liver disease: an in-depth review of the past, present, and future portopulmonary hypertension model for end-stage liver disease exception","volume":"28","author":"DuBrock","year":"2022","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.chest.2023.01.009_bib49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jlts.2000.6356","article-title":"Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.chest.2023.01.009_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TP.0000000000001517","article-title":"Frequency and outcomes of patients with increased mean pulmonary artery pressure at the time of liver transplantation","volume":"101","author":"DeMartino","year":"2017","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.chest.2023.01.009_bib51","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001085","article-title":"Outcomes of liver transplantation in treated portopulmonary hypertension patients with a mean pulmonary arterial pressure >\/=35\u00a0mm\u00a0Hg","volume":"6","author":"DuBrock","year":"2020","journal-title":"Transplant Direct"},{"issue":"1","key":"10.1016\/j.chest.2023.01.009_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.06.017","article-title":"Portopulmonary hypertension: an unfolding story","volume":"45","author":"Thevenot","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ACO.0b013e32833725c4","article-title":"Portopulmonary hypertension and right heart failure in patients with cirrhosis","volume":"23","author":"Ramsay","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"issue":"5","key":"10.1016\/j.chest.2023.01.009_bib54","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/lt.25871","article-title":"Planned initiation of venoarterial extracorporeal membrane oxygenation prior to liver transplantation in a patient with severe portopulmonary hypertension","volume":"27","author":"Barbas","year":"2021","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.chest.2023.01.009_bib55","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.28990","article-title":"Long-term outcome in liver transplantation candidates with portopulmonary hypertension","volume":"65","author":"Savale","year":"2017","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.chest.2023.01.009_bib56","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/TP.0000000000003490","article-title":"Clinical outcomes after liver transplantation in patients with portopulmonary hypertension","volume":"105","author":"Cartin-Ceba","year":"2021","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib57","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/TP.0000000000003248","article-title":"Long-term outcomes and survival in moderate-severe portopulmonary hypertension after liver transplant","volume":"105","author":"Sadd","year":"2021","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.chest.2023.01.009_bib58","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.200804-613OC","article-title":"Portopulmonary hypertension: survival and prognostic factors","volume":"178","author":"Le Pavec","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2023.01.009_bib59","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/TP.0000000000001666","article-title":"Predictors of waitlist mortality in portopulmonary hypertension","volume":"101","author":"DuBrock","year":"2017","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.chest.2023.01.009_bib60","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/lt.26091","article-title":"Pulmonary vascular resistance predicts mortality and graft failure in transplantation patients with portopulmonary hypertension","volume":"27","author":"Jose","year":"2021","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.chest.2023.01.009_bib61","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/TP.0000000000001981","article-title":"Does portopulmonary hypertension impede liver transplantation in cirrhotic patients? A French multicentric retrospective study","volume":"102","author":"Reymond","year":"2018","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.chest.2023.01.009_bib62","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1007\/s10620-014-3065-y","article-title":"Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era","volume":"59","author":"Salgia","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.chest.2023.01.009_bib63","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/lt.24625","article-title":"Portopulmonary hypertension: still an appropriate consideration for liver transplantation?","volume":"22","author":"Verma","year":"2016","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.chest.2023.01.009_bib64","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.transproceed.2016.12.006","article-title":"Comparison of post-liver transplantation outcomes in portopulmonary hypertension and pulmonary venous hypertension: a single-center experience","volume":"49","author":"Rajaram","year":"2017","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.chest.2023.01.009_bib65","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1600-6143.2006.01701.x","article-title":"The impact of treatment of portopulmonary hypertension on survival following liver transplantation","volume":"7","author":"Ashfaq","year":"2007","journal-title":"Am J Transplant"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223000430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223000430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:49:08Z","timestamp":1757926148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369223000430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0012369223000430"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2023.01.009","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Portopulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2023.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}